Canaccord Genuity Group Boosts Amgen Stock Price Target to $384.00

Amgen's stock price has been boosted by investment analysts at Canaccord Genuity Group, who have increased their target price to $384.00 from $366.00 in a recent research report.

This represents a potential downside of 1.70% from the stock's previous close of $390.63 on Wednesday.

The brokerage firm currently maintains a 'hold' rating on Amgen's stock, which has an average rating of 'hold' and a consensus price target of $361.30 among analysts.